Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
detrusitol sr 2 mg retard-kapseln
viatris pharma gmbh - tolterodinum - retard-kapseln - tolterodini tartras 2 mg corresp. tolterodinum 1.37 mg, hypromellosum, sacchari sphaerae corresp. saccharum 40.33 - 59.05 mg et maydis amylum, ethylcellulosum, triglycerida media, acidum oleicum, kapselhülle: gelatina, e 132, e 172 (flavum), e 171, drucktinte: lacca, e 171, propylenglycolum 0.0041 mg, simeticonum, pro capsula. - trattamento della vescica iperattiva - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
detrusitol sr 4 mg retard-kapseln
viatris pharma gmbh - tolterodinum - retard-kapseln - tolterodini tartras 4 mg corresp. tolterodinum 2.74 mg, sacchari sphaerae corresp. saccharum 80.66 – 118.10 mg et maydis amylum, hypromellosum, ethylcellulosum, triglycerida media, acidum oleicum, kapselhülle: gelatina, e 132, e 171, drucktinte: lacca, e 171, propylenglycolum, simeticonum, pro capsula. - trattamento della vescica iperattiva - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
pulmofor retard capsule
verfora sa - dextromethorphanum - capsule - dextromethorphani hydrobromidum 50 mg corresp. dextromethorphanum 36.6 mg, sacchari sphaerae corresp. saccharum 58.6 mg, acidi methacrylici et methylis methacrylatis polymerisatum 1:2, talcum, povidonum k 30, copolymerum methacrylatis butylati basicum, matériel de la capsule: gelatina, e 171 pro capsula. - toux, particulièrement la toux irritative - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
pentacarinat poudre pour solution injectable/ pour perfusion ou pour solution pour inhalation par nébulisateur
sanofi-aventis (suisse) sa - pentamidini diisethionas - poudre pour solution injectable/ pour perfusion ou pour solution pour inhalation par nébulisateur - pentamidini diisethionas 300 mg pro vitro. - pneumonie à pneumocystis carinii - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
triofan antitussif sciroppo
verfora sa - butamiratum - sciroppo - butamirati dihydrogenocitras 15 mg corrisp. butamiratum 9.3 mg sono di colore.: e 150a, conserv.: e 210, excipiens ad una soluzione per 10 ml. - tosse - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
triofan antitussif gocce
verfora sa - butamiratum - gocce - butamirati dihydrogenocitras 22,5 mg corrisp. butamiratum 13.95 mg, sono, conserv.: e 210, excipiens per soluzione pro 1 ml corrisp. 30 drop. - tosse - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
pulmofor sciroppo
verfora sa - dextromethorphanum - sciroppo - dextromethorphani hydrobromidum 25 mg corrisp. dextromethorphanum 18.3 mg, arom.: vanillinum, bergamottae aetheroleum e altri natrii cyclamas, saccharinum natricum, conserv.: e 211, excipiens ad una soluzione per 10 ml. - tosse, specialmente tosse secca, irritante - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
phytopharma hustensirup mit butamirat sirup
phytopharma s.a. - butamiratum - sirup - butamirati dihydrogenocitras 15 mg corrisp. butamiratum 9.3 mg sono di colore.: e 150a, conserv.: e 210, excipiens ad una soluzione per 10 ml. - tosse - synthetika
Ελβετία -
Ιταλικά -
Swissmedic (Swiss Agency for Therapeutic Products)
amavita dextromethorphan sirup
amavita health care ag - dextromethorphanum - sirup - dextromethorphani hydrobromidum 25 mg corrisp. dextromethorphanum 18.3 mg, arom.: vanillinum, bergamottae aetheroleum et alia, natrii cyclamas, saccharinum natricum, mantenuto.: e 211, excipiens annuncio solutionem pro 10 ml. - husten, insbesondere trockener reizhusten - synthetika